HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxidative activation of proguanil and dapsone acetylation in Thai soldiers.

Abstract
The prevalence of putative poor metaboliser (PM) phenotypes of proguanil oxidation in Caucasian populations is 3-10%. The PM frequency in Oriental populations is unknown. In this study the plasma metabolic ratios of proguanil and dapsone to their principal metabolites cycloguanil and monoacetyldapsone were determined in Thai soldiers receiving antifolate drug combinations for malaria prophylaxis. The distribution ratio of proguanil to cycloguanil (PROG/CYC) was highly skewed with no evidence of bimodality. Assuming subjects with a PROG/CYC ratio greater than 10 are PMs from studies in Caucasians, the incidence of PMs in the soldiers would be 18% (30 of 170). The mean PROG/CYC ratio for PMs in the Thai soldiers was 31.2 +/- 28.9 (n = 30) compared with 25.5 +/- 2.5 (n = 3) in a study of Caucasians. The corresponding values for putative EMs were 5.4 +/- 2.1 (n = 140) and 2.4 +/- 0.2 (n = 134). Similar to other Oriental populations, Thais were found to be predominantly (76%, 173 of 228) rapid acetylators of dapsone.
AuthorsM D Edstein, G D Shanks, P Teja-Isavadharm, K H Rieckmann, H K Webster
JournalBritish journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 37 Issue 1 Pg. 67-70 (Jan 1994) ISSN: 0306-5251 [Print] England
PMID8148220 (Publication Type: Journal Article, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Triazines
  • cycloguanil
  • Dapsone
  • monoacetyldapsone
  • Proguanil
Topics
  • Acetylation
  • Biotransformation
  • Chromatography, High Pressure Liquid
  • Dapsone (analogs & derivatives, blood, metabolism, therapeutic use)
  • Humans
  • Malaria (prevention & control)
  • Military Personnel
  • Oxidation-Reduction
  • Polymorphism, Genetic
  • Proguanil (blood, metabolism, therapeutic use)
  • Thailand
  • Triazines (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: